Percutaneous biliary interventions and complications in malignant bile duct obstruction

2016 ◽  
Vol 5 (5) ◽  
pp. 68-68 ◽  
Author(s):  
Hooman Yarmohammadi ◽  
Anne M. Covey
Keyword(s):  
Bile Duct ◽  
Bile Duct Obstruction ◽  
Duct Obstruction ◽  
Malignant Bile Duct Obstruction ◽  
Biliary Interventions

scholarly journals Feasibility and Safety of Endoluminal Radiofrequency Ablation as a Rescue Treatment for Bilateral Metal Stent Obstruction Due to Tumor Ingrowth in the Hilum: A Pilot Study

2021 ◽  
Vol 10 (5) ◽  
pp. 952
Author(s):  
Hoonsub So ◽  
Chi Hyuk Oh ◽  
Tae Jun Song ◽  
Hyun Woo Lee ◽  
Jun Seong Hwang ◽  
...  
Keyword(s):  
Radiofrequency Ablation ◽  
Bile Duct ◽  
Adverse Events ◽  
Bile Duct Obstruction ◽  
Metal Stents ◽  
Metal Stent ◽  
Duct Obstruction ◽  
Tumor Ingrowth ◽  
Malignant Bile Duct Obstruction ◽  
Hilar Bile Duct

Background. Radiofrequency ablation (RFA) is a palliative method known for its application in the endoscopic treatment of malignant bile duct obstruction. It may be a useful rescue method for metal stent malfunction caused by tumor ingrowth. This study aimed to examine the feasibility and safety of endoluminal RFA for occluded bilateral hilar metal stents due to tumor ingrowth in patients with malignant hilar bile duct obstruction. Methods: From March 2016 to June 2018, 11 patients with unresectable malignant hilar bile duct stricture with occluded bilateral hilar metal stents due to tumor ingrowth were enrolled. Endoluminal RFA was performed through a novel temperature-controlled catheter at a setting of 7 W power for 120 s with a target temperature of 80 °C via endoscopic retrograde cholangiopancreatography (ERCP). The patients’ demographics, clinical outcomes, and adverse events were investigated. Results: The median age was 64 (interquartile range, 54–72) years. All RFA procedures were successful. Clinical success was achieved in eight patients (72.7%). During the follow-up, eight patients (72.7%) showed stent dysfunction, and the median patency after RFA was 50 days (95% confidence interval (CI): 34–not available (NA)). All stent dysfunctions were successfully managed with ERCP. Ten patients died, and the median overall survival was 289 days (95% CI, 107–NA) from RFA to death. There was one case of mild abdominal pain after the procedure without serious adverse events. Conclusions: As a rescue therapy for occluded bilateral hilar metal stents due to tumor ingrowth, endoluminal RFA seemed to be safe and useful in selected patients.

Endoscopic palliation of malignant bile duct obstruction: Improvement in quality of life

1997 ◽  
Vol 45 (4) ◽  
pp. AB147 ◽  
Author(s):  
S. Sheman ◽  
G. Lehman ◽  
D. Earle ◽  
E. Lazaridis ◽  
J. Frakes ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Bile Duct ◽  
Bile Duct Obstruction ◽  
Duct Obstruction ◽  
Endoscopic Palliation ◽  
Malignant Bile Duct Obstruction

Palliation of Malignant Bile Duct Obstruction with Metallic Biliary Endoprostheses: Technique, Results, and Complications

1992 ◽  
Vol 3 (4) ◽  
pp. 665-671 ◽  
Author(s):  
Micheal J. Lee ◽  
Steven L. Dawson ◽  
Peter R. Mueller ◽  
Thorsten L. Krebs ◽  
Sanjay Saini ◽  
...  
Keyword(s):  
Bile Duct ◽  
Bile Duct Obstruction ◽  
Duct Obstruction ◽  
Malignant Bile Duct Obstruction ◽  
Biliary Endoprostheses

Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction

1998 ◽  
Vol 48 (6) ◽  
pp. 574-579 ◽  
Author(s):  
Finn Møller Pedersen ◽  
Annmarie Touborg Lassen ◽  
Ove B. Schaffalitzky de Muckadell
Keyword(s):  
Bile Duct ◽  
Randomized Trial ◽  
Sphincter Of Oddi ◽  
Bile Duct Obstruction ◽  
Duct Obstruction ◽  
Malignant Bile Duct Obstruction

PTU-021 The use of a novel endoscopically placed radiofrequency probe for the management of malignant bile duct obstruction

Gut ◽  
2010 ◽  
Vol 59 (Suppl 1) ◽  
pp. A56.3-A57
Author(s):  
A Steel ◽  
A Postgate ◽  
P Vlavianos ◽  
S Khorsandi ◽  
N Habib ◽  
...  
Keyword(s):  
Bile Duct ◽  
Bile Duct Obstruction ◽  
Duct Obstruction ◽  
Malignant Bile Duct Obstruction
Sign in / Sign up

Export Citation Format

Share Document